Prospect Heights, IL, United States of America

Chung-Hwai Yen

This inventor holds 2 USPTO granted patents. Top assignee: G.d. Searle & Company. Active years: 1988-1999.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Chung-Hwai Yen. Retrieved from https://idiyas.com/inventor/chung-hwai-yen

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 1988-1999

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Innovations by Chung-Hwai Yen

Introduction

Chung-Hwai Yen is a notable inventor based in Prospect Heights, IL (US). He has made significant contributions to the field of pharmaceuticals, particularly in the treatment and prevention of ulcers. With a total of 2 patents, his work has the potential to impact many lives.

Latest Patents

Chung-Hwai Yen's latest patents include two innovative compounds. The first patent, titled "2-�(1H-benzimidazol-2-ylsulfinyl)methyl!benzenamines," relates to compounds that are useful in the treatment and prevention of ulcers. The second patent, "2-[(imidazo[1,2-a]pyridin-3-ylmethyl)sulfinyl]-1H-benzimidazoles," also focuses on compounds beneficial for the same medical purpose.

Career Highlights

Chung-Hwai Yen is associated with G.D. Searle & Company, where he has been instrumental in developing new pharmaceutical solutions. His expertise in medicinal chemistry has led to advancements that could enhance patient care.

Collaborations

Chung-Hwai Yen has collaborated with notable colleagues, including Gilbert W. Adelstein and Alan E. Moormann. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.

Conclusion

Chung-Hwai Yen's contributions to the field of pharmaceuticals through his patents demonstrate his commitment to improving healthcare. His work continues to pave the way for new treatments that can benefit many individuals suffering from ulcers.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…